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Abstract
Background: Atrial fibrillation, the world’s most common arrhythmia, is a leading risk factor for stroke, a disease striking
nearly 1.6 million Indians annually. Early detection and management of atrial fibrillation is a promising opportunity to prevent
stroke but widespread screening programs in limited resource settings using conventional methods is difficult and costly.
Objective: The objective of this study is to screen people for atrial fibrillation in rural western India using a US Food and Drug
Administration-approved single-lead electrocardiography device, Alivecor.
Methods: Residents from 6 villages in Anand District, Gujarat, India, comprised the base population. After obtaining informed
consent, a team of trained research coordinators and community health workers enrolled a total of 354 participants aged 50 years
and older and screened them at their residences using Alivecor for 2 minutes on 5 consecutive days over a period of 6 weeks
beginning June, 2015.
Results: Almost two-thirds of study participants were 55 years or older, nearly half were female, one-third did not receive any
formal education, and more than one-half were from households earning less than US $2 per day. Twelve participants screened
positive for atrial fibrillation yielding a sample prevalence of 5.1% (95% CI 2.7-8.7). Only one participant had persistent atrial
fibrillation throughout all of the screenings, and 9 screened positive only once.
Conclusions: Our study suggests a prevalence of atrial fibrillation in this Indian region (5.1%) that is markedly higher than has
been previously reported in India and similar to the prevalence estimates reported in studies of persons from North America and
Europe. Historically low reported burden of atrial fibrillation among individuals from low and middle-income countries may be
due to a lack of routine screening. Mobile technologies may help overcome resource limitations for atrial fibrillation screening
in underserved and low-resource settings.
(JMIR Public Health Surveill 2016;2(2):e159)   doi:10.2196/publichealth.6517
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Introduction
Atrial fibrillation is the world’s most common cardiac
arrhythmia and, if untreated, increases the risk of stroke by
upwards of five-fold [1]. Atrial fibrillation–related
complications, particularly stroke, have reached epidemic
proportions in low and middle-income countries. This is
particularly true in India, where approximately 1.6 million
persons suffer a stroke annually [2]. A growing number of
people in India are affected by risk factors for atrial fibrillation,
including hypertension and diabetes mellitus [3], and the
contribution of atrial fibrillation to the ongoing stroke epidemic
in India is unclear and understudied [4]. In India, where the
majority of health care costs are out of pocket [5], routine
evaluations using conventional electrocardiography (ECG) to
diagnose atrial fibrillation are not standard of care. Therefore,
an understanding of the atrial fibrillation epidemiology becomes
dependent on systematic screening programs. Single-time,
point-of-care screening programs face difficulties of their own
because of the paroxysmal and minimally symptomatic nature
of the majority of atrial fibrillation cases.
Here we report findings of a study to screen people for atrial
fibrillation in rural western India using a US Food and Drug
Administration (FDA)-approved single-lead ECG device,
Alivecor, to overcome traditional constraints of dysrhythmia
screening [6].
Methods
Residents from 6 different villages in Anand District, Gujarat,
India, comprised the base population. These 6 villages were
randomly selected from a list of 30 villages where our
community health workers are present. Trained research
coordinators worked with the community health workers who
were familiar with the layout of their respective villages and
enrolled 60 participants from each village. Villages in India are
typically organized by occupation-based colonies (fariyahs),
and an equal number of participants were recruited from all
fariyahs. The residents of every third house in each fariyah were
approached for enrollment through the use of a systematic
random sample. After obtaining informed consent, a team of
trained research coordinators and community health workers
enrolled a total of 355 participants aged 50 years and older to
participate in the study.
The study included two components: (1) screening using
FDA-approved single-lead ECG device, Alivecor, and (2)
collection of pulse data to develop an automated arrhythmia
detection mobile app that can be used in low-resource settings
[7,8]. Both Alivecor and pulse data were recorded serially for
2 minutes each on 5 consecutive days over a period of 6 weeks
beginning June, 2015. During screening, participants sat
cross-legged, resting the smartphone (iPhone 4S) in their lap to
stabilize the phone and reduce excess motion that could interfere
with the recordings (Figure 1). Additionally, on the day of
enrollment, participants responded to a questionnaire that
collected information related to their demographic
characteristics, lifestyle habits, and past medical history.
The Alivecor device malfunctioned for two weeks, and therefore
120 participants from two villages were not screened for atrial
fibrillation using Alivecor and were excluded from this study.
Study staff uploaded ECG and pulse check recordings to a
secure, Web-accessible Research Electronic Data Capture study
database. Because pulse data were collected with the intention
of developing an arrhythmia detection app based on the results
of this pilot study, our outcome of atrial fibrillation was
determined based solely on the ECG results from the
FDA-approved Alivecor device. A board-certified cardiologist
reviewed all ECG tracings for participants who had abnormal
rhythm findings based on the automated Alivecor algorithm
(Figure 2). Any participant found to have atrial fibrillation was
referred to a study cardiologist located at a regional academic
health center. Due to constraints in our available resources, our
research staff did not follow up with participants after screening
to assess whether any clinical plan was initiated.
A randomly selected 20% subsample of normal ECG tracings
were reviewed by two trained study staff members, and
discordant readings were adjudicated by the study cardiologist.
Thus, a board-certified cardiologist reviewed the ECG tracings
of all participants who were determined to have positive
screening findings for the presence of atrial fibrillation. The
study received institutional review board approval from the
University of Massachusetts Medical School and HM Patel
Center for Medical Care and Education. Descriptive statistics
were utilized to describe the characteristics of study participants.
Sociodemographic and comorbid factors were compared across
different age groups using Fisher exact tests. Prevalence rates
of atrial fibrillation were calculated in a standard manner with
accompanying 95% confidence intervals. Given the limited
sample size in our pilot investigation and the use of the Alivecor
ECG as the source for gold standard measurement, we did not
calculate performance measures.
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Figure 1. Community health worker screening a study participant for atrial fibrillation using a single-lead ECG device.
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Figure 2. Adjudication of atrial fibrillation screening results.
Results
Almost two-thirds of study participants were 55 years or older,
nearly half were female, one-third did not receive any formal
education, and more than one-half were from households earning
less than US $2 per day (Table 1).
Twelve participants screened positive for atrial fibrillation
yielding a sample prevalence of 5.1% (95% CI 2.7-8.7) (Figure
2); the characteristics of these individuals are shown in Table
2.
Only one participant had persistent atrial fibrillation throughout
all of the screenings; 9 screened positive only once. The
cumulative prevalence of atrial fibrillation in this population
according to increasing number of screenings is presented in
Table 3.
The first screening only identified 7 participants with a positive
screen for atrial fibrillation. The remaining 5 participants who
screened positive for atrial fibrillation were identified at the
fourth screening. A comparison of the 235 participants included
in the analyses, with the 120 excluded participants, revealed no
meaningful differences between the two groups (see Multimedia
Appendix 1 for details).
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Table 1. Sociodemographic, lifestyle, and health characteristics of 234 participants from rural Gujarat, India, screened for arrhythmias, stratified by
age groups.
Age group (%)
P valuea65+55-6550-55N
.0956.355.071.4140Femaleb
.19Education
35.127.030.770None
58.459.650.012910thgrade or less
6.513.519.429More than 10thgrade
<.0019.129.945.860Works for pay
.03Daily household incomec
31.728.133.971Less than $1
31.731.514.562$1-$2
15.220.237.153$2-$4
21.520.214.544More than $4
0.2511.314.37.937Smoking history
0.0321.322.033.358Chew tobacco
0.0248.834.127.087Hypertension
0.3711.35.59.520Diabetes
0.3012.58.84.821Hypercholesterolemia
aFisher exact test.
bOne participant had completed the screening and thus was included in the analyses but did not respond to the questionnaire.
cBased on a conservative exchange rate of 1 USD = 60 INR for 2015 calendar year.
Table 2. Characteristics of 12 atrial fibrillation positive cases identified by a cardiologist review of single-lead ECG recording.
HypertensionSmoking# positivebIndex positiveaAgeGender
NoNo1/3350-55Female1
NoNo1/3155-60Female2
NoNo5/5160-65Female3
YesNo2/5160-65Female4
YesNo1/4175-80Female5
NoNo3/4180-85Female6
YesYes1/3350-55Male7
NoYes1/1155-60Male8
YesNo1/1160-65Male9
NoYes1/5470-75Male10
YesNo1/3375-80Male11
YesNo1/5475-80Male12
aRefers to the number of screening when atrial fibrillation was first recognized.
bRefers to the total number of positive screenings for a given participant.
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Table 3. Cumulative prevalence of atrial fibrillation by number of screenings.
Cumulative prevalence (95% CI)Screening number
3.0 (1.2-6.1)1
3.0 (1.2-6.1)2
4.3 (2.1-7.7)3
5.1 (2.7-8.7)4
5.1 (2.7-8.7)5
Discussion
Principal Findings
Our study suggests a prevalence of atrial fibrillation in this
Indian region (5.1%) that is markedly higher than has been
previously reported in India and similar to the prevalence
estimates reported in studies of persons from North America
and Europe [1,9,10]. This finding is noteworthy and challenges
conventional wisdom that individuals of European descent have
higher rates of atrial fibrillation than individuals of Asian
descent [1].
Current understanding of the global epidemiology of atrial
fibrillation is dependent on robust surveillance systems and high
quality community-based studies, but there remains a paucity
of such investigations outside of North America and Europe,
particularly in countries with less developed health systems
[10]. A 2012 meta-analysis of community-based screening
studies identified only one study from India [10]. That study
was conducted in a tribal Himalayan village and found only one
case of atrial fibrillation among 984 screened individuals, a
prevalence rate of 0.1% [9]. However, 94% of participants in
that study were less than 65 years old and thus not representative
of the age profile of typical atrial fibrillation patients. A recently
published opportunistic screening study of festival attendees
reported a slightly higher but still low prevalence of atrial
fibrillation (0.5%) among individuals 50 years of age or older
[11]. Reasons for the discrepancies between our results and
prior studies may include the shortcomings of opportunistic
screening efforts involving younger individuals and the use of
a single spot-check for atrial fibrillation. Our approach, in
contrast to the two prior studies in India, utilized a randomized
home-based serial screening of participants aged 50 years and
older in order to detect paroxysmal and persistent atrial
fibrillation. The higher yield from multiple rhythm checks versus
a single check for the detection of paroxysmal atrial fibrillation
in the community has been emphasized by other studies [12]
and is made evident by our findings. Namely, we observed that
out of the 12 participants who screened positive for atrial
fibrillation, only one had persistent atrial fibrillation. Moreover,
5 participants who were ultimately found to have paroxysmal
atrial fibrillation did not have atrial fibrillation detected during
their first screen.
Recently, there has been increased attention in North America
and Europe to leverage mobile technology for the screening of
persons with undetected atrial fibrillation [12,13]. The
establishment of the National Programme for Prevention and
Control of Stroke by the Indian government supports the
importance of stroke prevention in India. However, due to the
cost of ECG-based screening programs and paucity of trained
health professionals in many regions, atrial fibrillation screening
has not been possible to date. Our efforts suggest that by
engaging community health workers to use novel mobile
technologies for arrhythmia monitoring we can screen large
numbers of Indians for atrial fibrillation. Our capacity to recruit
and serially screen residents of the rural Anand community was
strengthened by a long-standing relationship between
investigators and community health workers in India.
Limitations
The findings of our study need to be interpreted with appropriate
caution given several concerns and limitations. First, this study
is based on a relatively small sample size of 235 participants.
Therefore, we have presented information about sample sizes
and accompanying 95% confidence intervals to demonstrate
the range of possible prevalence estimates consistent with the
variability observed in our data. Second, we did not perform a
gold standard 12-lead ECG to confirm our positive screening
findings. It is important to note, however, that Alivecor devices
are FDA-approved and are widely used by cardiologists in
diverse clinical settings [14]. Lastly, our cross-sectional study
design limits our ability to assess any potential outcomes
associated with atrial fibrillation or characterize the clinical
presentation of atrial fibrillation in more detail. Therefore, future
efforts should explore the feasibility and costs associated with
replicating our approach in other environments to define the
accuracy of the automated algorithms employed in larger and
more diverse cohorts, to create referral mechanisms which can
accommodate newly identified patients, to more systematically
characterize the clinical presentation of atrial fibrillation (eg,
valvular diseases, comorbidities, psychosocial impact), and to
demonstrate reduced stroke rates through the primary prevention
of stroke in screened populations.
Conclusions
In conclusion, our study has two important implications: (1)
mobile technologies may help overcome resource limitations
for screening adults for atrial fibrillation in underserved and
low-resource settings and (2) serial screening for atrial
fibrillation enhances the ability to identify persons at risk for
atrial fibrillation.
 
JMIR Public Health Surveill 2016 | vol. 2 | iss. 2 | e159 | p.6http://publichealth.jmir.org/2016/2/e159/
(page number not for citation purposes)
Soni et alJMIR PUBLIC HEALTH AND SURVEILLANCE
XSL•FO
RenderX
Acknowledgments
We thank Ms Nada Esa, Ms. Dharti Patel, Ms Ami Brahmbhatt, and Mr Utsav Patel for supporting data collection efforts. We
are grateful to Dr. Jay Himmelstein and the Office of Health Policy and Technology at the University of Massachusetts Medical
School for supporting our research.
AS received support from the National Center for Advancing Translational Sciences (TL1-TR001454), and JA received support
from the National Institute on Minority Health and Health Disparities (P60-MD006912-05). DDM’s time was supported by
KL2RR031981, 1R15HL121761-01A1, 1UH2TR000921-02, and 1R01HL126911-01A1 from the National Heart, Lung, and
Blood Institute.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes
of Health.
Conflicts of Interest
DDM discloses equity stakes or consulting relationships with Flexcon, Bristol-Myers Squibb, Mobile Sense, ATRIA, and Boston
Biomedical Associates. He has also received research funding from Sanofi Aventis, Otsuka Pharmaceuticals, Philips Healthcare,
Biotronik, and Pfizer.
Multimedia Appendix 1
Comparison of sociodemographic, lifestyle, and health characteristics of participants that were excluded versus included in the
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